Kylie Vuong1, Kevin McGeechan2, Bruce K Armstrong1, Anne E Cust1. 1. Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia. 2. Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Abstract
IMPORTANCE: Currently, there is no comprehensive assessment of melanoma risk prediction models. OBJECTIVE: To systematically review published studies reporting multivariable risk prediction models for incident primary cutaneous melanoma for adults. EVIDENCE REVIEW: EMBASE, MEDLINE, PREMEDLINE, and Cochrane databases were searched to April 30, 2013. Eligible studies were hand searched and citation tracked. Two independent reviewers extracted information. FINDINGS: Nineteen studies reporting 28 melanoma prediction models were included. The number of predictors in the final models ranged from 2 to 13; the most common were nevi, skin type, freckle density, age, hair color, and sunburn history. There was limited reporting and substantial variation among the studies in model development and performance. Discrimination (the ability of the model to differentiate between patients with and without melanoma) was reported in 9 studies and ranged from fair to very good (area under the receiver operating characteristic curve, 0.62-0.86). Few studies assessed internal or external validity of the models or their use in clinical and public health practice. Of the published melanoma risk prediction models, the risk prediction tool developed by Fears and colleagues, which was designed for the US population, appears to be the most clinically useful and may also assist in identifying high-risk groups for melanoma prevention strategies. CONCLUSIONS AND RELEVANCE: Few melanoma risk prediction models have been comprehensively developed and assessed. More external validation and prospective evaluation will help translate melanoma risk prediction models into useful tools for clinical and public health practice.
IMPORTANCE: Currently, there is no comprehensive assessment of melanoma risk prediction models. OBJECTIVE: To systematically review published studies reporting multivariable risk prediction models for incident primary cutaneous melanoma for adults. EVIDENCE REVIEW: EMBASE, MEDLINE, PREMEDLINE, and Cochrane databases were searched to April 30, 2013. Eligible studies were hand searched and citation tracked. Two independent reviewers extracted information. FINDINGS: Nineteen studies reporting 28 melanoma prediction models were included. The number of predictors in the final models ranged from 2 to 13; the most common were nevi, skin type, freckle density, age, hair color, and sunburn history. There was limited reporting and substantial variation among the studies in model development and performance. Discrimination (the ability of the model to differentiate between patients with and without melanoma) was reported in 9 studies and ranged from fair to very good (area under the receiver operating characteristic curve, 0.62-0.86). Few studies assessed internal or external validity of the models or their use in clinical and public health practice. Of the published melanoma risk prediction models, the risk prediction tool developed by Fears and colleagues, which was designed for the US population, appears to be the most clinically useful and may also assist in identifying high-risk groups for melanoma prevention strategies. CONCLUSIONS AND RELEVANCE: Few melanoma risk prediction models have been comprehensively developed and assessed. More external validation and prospective evaluation will help translate melanoma risk prediction models into useful tools for clinical and public health practice.
Authors: Giuseppe Palmieri; Maria Colombino; Milena Casula; Mario Budroni; Antonella Manca; Maria Cristina Sini; Amelia Lissia; Ignazio Stanganelli; Paolo A Ascierto; Antonio Cossu Journal: Melanoma Manag Date: 2015-05-18
Authors: Annette M Molinaro; Leah M Ferrucci; Brenda Cartmel; Erikka Loftfield; David J Leffell; Allen E Bale; Susan T Mayne Journal: Am J Epidemiol Date: 2015-04-08 Impact factor: 4.897
Authors: Catherine M Olsen; Rachel E Neale; Adèle C Green; Penelope M Webb; David C Whiteman Journal: J Invest Dermatol Date: 2014-12-30 Impact factor: 8.551
Authors: K Vuong; B K Armstrong; M Drummond; J L Hopper; J H Barrett; J R Davies; D T Bishop; J Newton-Bishop; J F Aitken; G G Giles; H Schmid; M A Jenkins; G J Mann; K McGeechan; A E Cust Journal: Br J Dermatol Date: 2019-09-22 Impact factor: 9.302
Authors: A E Cust; C Badcock; J Smith; N E Thomas; L E Haydu; B K Armstrong; M H Law; J F Thompson; P A Kanetsky; C B Begg; Y Shi; A Kricker; I Orlow; A Sharma; S Yoo; S F Leong; M Berwick; D W Ollila; S Lo Journal: Br J Dermatol Date: 2019-11-27 Impact factor: 9.302
Authors: John R Davies; Yu-mei Chang; D Timothy Bishop; Bruce K Armstrong; Veronique Bataille; Wilma Bergman; Marianne Berwick; Paige M Bracci; J Mark Elwood; Marc S Ernstoff; Adele Green; Nelleke A Gruis; Elizabeth A Holly; Christian Ingvar; Peter A Kanetsky; Margaret R Karagas; Tim K Lee; Loïc Le Marchand; Rona M Mackie; Håkan Olsson; Anne Østerlind; Timothy R Rebbeck; Kristian Reich; Peter Sasieni; Victor Siskind; Anthony J Swerdlow; Linda Titus; Michael S Zens; Andreas Ziegler; Richard P Gallagher; Jennifer H Barrett; Julia Newton-Bishop Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-02-24 Impact factor: 4.254